Recent

% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • supermba_2000 supermba_2000 Nov 28, 2012 11:17 PM Flag

    Avanir Pharmaceuticals Stock Rating Reaffirmed by Canaccord Genuity (AVNR)

    "Avanir Pharmaceuticals Stock Rating Reaffirmed by Canaccord Genuity (AVNR)
    Posted by LUSA Staff on Nov 28th, 2012

    Avanir Pharmaceuticals (NASDAQ: AVNR)‘s stock had its “buy” rating restated by analysts at Canaccord Genuity in a research report issued to clients and investors on Wednesday.

    Separately, analysts at Cowen initiated coverage on shares of Avanir Pharmaceuticals in a research note to investors on Monday, October 1st. They set an “outperform” rating on the stock.

    Avanir Pharmaceuticals traded up 5.08% on Wednesday, hitting $2.795. Avanir Pharmaceuticals has a 1-year low of $1.77 and a 1-year high of $4.05. The company’s market cap is $380.6 million."

 
AVNR
16.960.00(0.00%)Jan 12 4:00 PMEST